Prostate biopsy with fusion imaging of magnetic resonance imaging and transrectal ultrasound

Prostate biopsy with fusion imaging of magnetic resonance imaging and transrectal ultrasound - Prostate biopsy with fusion imaging of magnetic resonance imaging and transrectal ultrasound

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034165

Enrollment

400

Registered

2018-09-17

Start date

2018-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Biojet system

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: ?Serum PSA level: 4.0-20.0ng/ml ?Significant cancer was suspected by MRI ?To obtain informed consent

Exclusion criteria

Exclusion criteria: ?Anal stenosis ?Diabetes ?Infection nest in perineum site ?Clear hypoechoic area was detected by US on cancer suspecting region

Design outcomes

Primary

Measure	Time frame
Cancer detection rate, target biopsies for each cancer-suspicious lesion would be performed using the BioJet system.	—

Secondary

Measure	Time frame
Evaluation of safety	—

Countries

Japan

Contacts

Public ContactHiroshi Sasaki

Jikei University School of Medicine Department of Urology

hs06@jikei.ac.jp03-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026